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Abstract. A  family of proteins homologous to the 
cdc25 gene product of the fission yeast bear specific 
protein tyrosine phosphatase activity involved in the 
activation of the p34~a-cyclin B kinase. Using atfinity- 
purified antibodies raised against a  synthetic peptide 
corresponding to the catalytic site of the cdc25 phos- 
phatase, we show that cdc25 protein is constitutively 
expressed throughout the cell cycle of nontransformed 
mammalian fibroblasts and does not undergo major 
changes in protein level. By indirect immunofluores- 
cence, cdc25 protein is found essentially localized in 
the nucleus throughout interphase and during early 
prophase. Just before the complete nuclear envelope 
breakdown at the prophase-prometaphase boundary, 
cdc25 proteins are redistributed throughout the cyto- 
plasm.  During metaphase and anaphase, cdc25 stain- 
ing remains distributed throughout the cell and ex- 
cludes the condensed chromosomes. The nuclear 
locale reappears during telophase. In light of the re- 
cent data describing the cytoplasmic localization of cy- 
clin B protein (Pines, J., and T.  Hunter.  1991. J.  Cell 
Biol. 115:1-17),  the data presented here suggest that 
separation in two distinct cellular compartments of the 
cdc25 phosphatase and its substrate p34~c2-cyclin B 
may be of importance in the regulation of the cdc2 ki- 
nase activity. 
p34 r162 is an implicit component in the regulatory mech- 
anisms which bring about the coordinate division of cells. 
Present throughout the eukaryotic phyla, p34  ~  appears to 
undergo distinct activation coincident with the entry of cells 
into mitosis (Doric,  1990; Nurse,  1990).  This  activation 
event involves its association  with one or more regulatory 
proteins termed cyclins. At least five of such proteins have 
been reported, although little is known of their precise func- 
tions  or relationship  in the events that bring about p34  ~2 
kinase induction (Hunt, 1991; Hunter and Pines, 1991; Pines, 
1991). In addition to the association  with cyclin proteins, 
p~a  kinase activation  also involves changes  in the phos- 
phorylation state of the p34  ~: catalytic subunit. While dif- 
ferent phosphorylation levels can be identified for p34  ~a, 
recent mutational analysis revealed that the dephosphoryla- 
tion of two particular aminoacid residues at the NH2-ter- 
minus of the protein was implicit in the activation of the mi- 
totic form of the p34  ~c2 kinase (Clarke and Karsenti,  1991; 
Krek and Nigg,  1991; Norbury et al.,  1991). The human 
homologue of cdc25 has been shown to bring about the spe- 
cific dephosphorylation and activation  of p34~do2-cyclin B 
kinase in an in vitro assay involving highly purified protein 
components (Strausfeld et al., 1991). Indeed, dephosphory- 
lation of tyrosine 15 is directly controlled by p34 ~2 specific 
protein phosphatase homologous to the edc25 gene product 
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of Schizosaccharomyces  pombe (Dunphy and Kumagai, 1991; 
Gautier et al.,  1991; Lee et al.,  1992; Millar et al.,  1991; 
for review see Millar and Russell,  1992). 
We have previously  shown that the presence of activated 
p34 cdc: kinase in  synchronized mammalian cells was  suf- 
ficient to induce phenotypic changes similar to those ob- 
served during prophase (Lamb et al.,  1990). Since p34 cdc~ 
protein levels appear to remain constant throughout the cell 
division  cycle of mammalian cells,  this  would imply that 
regulation of p34 cd~2 kinase activity must involve, in part, 
differential synthesis of factors which bring about the activa- 
tion of the kinase. In the present study, we have examined the 
expression and cellular distribution  of cdc25 protein to de- 
termine if fluctuations during the cell cycle may play a role 
in the control of p34  ~dc2 activity in nontransformed mam- 
malian cells.  Immunoblotting  and indirect immunofluores- 
cence analysis reveals that as in the transformed HeLa cells 
(Millar et al.,  1991), cdc25 protein levels remain constant 
throughout the cell cycle,  implying that posttranslational 
modifications and/or compartmentalization mechanisms must 
be involved in the activation of cdc25 phosphatase. 
Materials and Methods 
Peptide Synthesis 
Solid phase synthesis of CEFSSKRGPDLLR peptide (referred to as C5XR1) 
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use of  polyacrylic  resin (Caias et ai., 1985), 9-fluorenyl  methyl oxycarbonyl 
as temporary a-amino acid group protection, and benzotriazol-l-yl-oxy-tris- 
(dimethylamino)-phosphonium-hexnfluorophosphate  as coupling reagent. 
Peptide was desaited on Sephadex  (310 column and purified  on reverse  phase 
high pressure liquid chromatography on a Nucleosil 08 column using a 
linear  gradient of 0.1% aqueous trifluoroacetic acid with acetonitrile. 
Purified peptide was coupled to thyroglobulin or to BSA by the use of 
m-rnaieydobenzoyl-N-hydroxysulfosuccinimide  ester  (Pierce  Chemical 
Co., Arlington Heights, IL). Peptide-protein conjugates were filtered on 
PD10 column (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated 
in PBS. 
Polyclonal Antibody Production and Purification 
Male New Zealand rabbits were injected subcutaneously with 300 izg of 
thyroglobuline-CSXR1 peptide conjugate in complete Freund adjuvant. 
Animals were boosted every 2 wk with 100 #g of the same preparation in 
incomplete Freund adjuvant, and bled 8-12 d after each injection. Antisera 
were purified using BSA-peptide conjugate coupled to CNBr-sepharose  4B 
(Pharmacia Fine Chemicals) as described elsewhere (Girard et al., 1991). 
Cell Culture and Synchronization 
Rat embryonic fibroblasts  REF52 (McClure et al., 1982) and human fibro- 
blasts HS68 (CRL-1365) were cultured in DME supplemented with 7% 
FCS, Hela cells in 10%  FCS DME, in 60-ram plastic dishes and acid- 
washed glass coverslips. Cells were grown at 37~  in a humidified atmo- 
sphere containing 5 % CO2/95  % air, until they reached 75 % confluence. 
REF52 and HS68 cells were then made quiescent through 30 h of serum 
deprivation. Synchronized cells were prepared as follows: quiescent cells 
were restimulated  through serum addition, and grown at 37~  then prepared 
for Western blot or immunnfluorescence  at 1-h intervals following serum 
stimulation. 
Western Blotting 
Synchronized cells obtained as mentioned above were washed in PBS at 
room temperature and scraped in SDS boiling sample buffer (Lamb et al., 
1990). Cell extracts were separated on 12 % SDS-PAGE  and proteins were 
transferred to nitrocellulose. Nitrocellulose sheets were saturated in 3 % 
nonfat dried milk in 25 mM Tris-HC1, pH 7.5, 200 mM NaC1 (TBS) for 
1 h, then incubated with anti-cdc25 peptide antibody ,CSXR1 (concentra- 
tion 0.67 mg/ml) diluted 1:2,000 in the same buffer for I h at room tempera- 
ture. After washes in TBS containing 0.05  % Tween 20, HRP-conjugated 
anti-rabbit (Amersham Corp.) was added 1:10,000 for 1 h. Detection of the 
immune signal was done using ECL Western blotting detection system 
(Amersham Corp,). For competition experiments, 7 ~g of c~CSXR1 were 
reacted with 75 ~,g of the immune peptide in a final volume of 200 ~1 for 
1 h at room temperature, then diluted 1:2,000 in TBS and used for Western 
blotting  as described above. 
Immunofluorescence 
Cells growing onto acid-washed  coverslips were fixed in 3.7 % formalin in 
PBS for 5 min, followed  by extraction in -20~  acetone for 1 min. After 
washes in PBS and saturation in PBS containing 1% BSA for 5 rain, incuba- 
tion with anti-cdc25 antibody c~CSXR1 was performed for 1 h at 37~ 
Reaction was followed by incubating biotinylated antirabbit (Amersham 
Corp.) for 1 h then streptavidin Texas red conjugated (Amersham Corp.) 
for 30 min. After washes in PBS, cells were incubated 1 min in PBS/BSA 
containing Hoechst dye (1 ~g/ml) to visualize DNA, washed in water, and 
mounted in  Airvol.  Fluorescent and phase-contrast micrographs were 
recorded on Zeiss Axiophot using Kodak Tri X pan and Technical pan, 
respectively. 
For competition experiment, 20 ~g of cdc25 peptide were incubated with 
anti aCSXRI (concentration 0.67 mg/mi, dilution 1:100, final volume 100 
/~1) for 1 h at room temperature. This solution was then used as primary 
antibody and the immunofluorescence  reaction  was continued as described 
above. For double immunofluorescence  staining for cdc25 and lamins A and 
C, serum synchronized  HS68 cells were fixed in formalin and acetone ex- 
tracted 22 h aRer serum restimulation, then incubated with ,CSXR1 anti- 
bodies and monoclonal antihuman lamins A and C (Heald and McKeon, 
1990). Reaction  was continued with the incubations of biotinylated  antirab- 
bit antibodies followed by streptavidin Texas red,  and fluorescein-con- 
jugated goat antimouse antibodies (Organon Technika, Fresnes, France). 
Cells were stained for DNA with Hoechst dye before mounting  as described 
elsewhere (Girard et ai., 199D. 
Results 
Expression of  cdc25 Protein in Nontransformed 
Mammalian Fibroblasts 
To  examine the expression and cellular distribution of the 
cdc25 gene product in mammalian cells, we have raised anti- 
bodies to  a  peptide sequence  of cdc25  protein conserved 
among various species. This sequence CEFSSKRGPDLLR 
(referred to as CSXR1) (Fig. 1 B) has been shown to belong 
to the phosphatase consensus site of cdc25  (Gautier et al., 
1991;  Millar et al.,  1991);  particularly, the motif C5XR is 
conserved throughout evolution and is also present in other 
protein phosphatases such as human T  cell PTP or vaccinia 
virus  PTP  (Guan  et  al.,  1991;  Streuli et al.,  1990),  and 
represents the catalytic site of the cdc25 phosphatase activ- 
ity. The CSXR1  sequence is identical to the corresponding 
region of a  starfish cdc25  protein that was determined by 
DNA sequence analysis of starfish cdc25 gene,  cloned by 
PCR  using  degenerate  primers  as  previously  described 
(Sadhu et al., 1990). We have also synthesized a second pep- 
tide,  -CSXR2  (Fig.  1  B),  representing  the  consensus  se- 
quence for the cdc25 family in this region. Rabbits were im- 
munized with peptide C5XR1 coupled to thyroglobuline, and 
antiserum  was  affinity  purified  using  CSXRI-BSA  con- 
jugates coupled to Sepharose. The specificity  of the resulting 
antibody (referred to as aCSXR1) is shown in Fig.  1 A. By 
Western blot, otC5XR1 detects a major protein species of rel- 
ative molecular mass of 67  kD in G2-phase human fibro- 
blasts HS68  cell extract (Fig.  1,  lane/),  a  second smaller 
protein species at 38 kD as revealed by a longer exposure of 
the ECL blot (Fig.  1,  lane 5),  and three protein species in 
G2-phase REF52 cell extract (Fig. 1, lane 2) of relative mo- 
lecular mass 75, 67,  and 38 kD. The same three bands are 
also observed in HeLa cell extract. (data not shown). Prein- 
cubation of otC5XRI  antibodies with C5XR1  and  CSXR2 
peptides before Western blot completely abolished all three 
protein species in REF52 cells (Fig. 1, lane 4), and both the 
38 and 67 kD form in HS68 cells (Fig. 1, lane 3), confirming 
the specificity of the affinity-purified antiserum. As presented 
in Fig.  1 (lane 6), ccCSXR1  antibody is also able to detect 
bacterially expressed human  p55  ~25.  o~CSXR1  antibodies 
were also specifically  reactive on immunoblot against human 
cdc25 protein, immunoprecipitated from HeLa cell extracts 
with different polyclonal antibodies raised against the entire 
human  cdc25  protein.  Furthermore,  these  antibodies  are 
also capable of inhibiting cdc25 phosphatase activity in a 
p34~2-cyclin B  kinase dephosphorylation assay  (data not 
shown). The major 67-kD form probably represents the full- 
length cdc25 gene product, while the 38-kD form is likely 
to be a fragment resulting from partial proteolysis. The up- 
per 75-1d) form seen in REF52 cells might be another form 
of cdc25 protein, since a protein species of similar molecular 
mass  is observed in  HeLa cells (Galaktionov and  Beach, 
1991),  and  several cdc25  genes have been isolated in hu- 
man cells (cdc25  A  and B,  Galaktionov and Beach,  1991; 
cdc25 C, Sadhu et ai., 1990; Nagata et al., 1991). All these 
results have been confirmed with two other polyclonal anti- 
cdc25  antibodies,  raised against bacterially expressed hu- 
The Journal of Cell Biology, Volume 118, 1992  786 Figure L Characterization of the afffinity-purified  anti-cdc25 peptide antibodies. Peptide sequence termed C5XR1, corresponding to the 
putative catalytic site of the starfish cdc25 protein phosphatase, was synthesized  as described in Materials and Methods and used to immu- 
nize rabbits. Polyclonal  antiserum was affinity  purified using C5XR1-BSA conjugated  coupled to sepharose, and used for Western blotting 
as described in Materials and Methods, using the ECL system (Amersham Corp.) for detection of the immune signal. (,4) Western blot 
of cell extracts from G2-phase human HS68 fibroblasts (lane 1) and G2-phase REF52 cells (lane 2) using anti-ode25 peptide antibody 
c~C5XR1. Arrowed on the left is the main protein species detected both in REF52 and HS68: open square at 67 kD together with two 
additional bands detected in REF52 cells, one at 75 kD (closed circle) and one at 38 kD (closed square), also detected in HS68 cells after 
a longer exposure of  the ECL blot (lane 5). Molecular masses are given in kilodaltons. Preincubation  of  anti-edc25 antibodies with peptides 
C5XR1/C5XR2 prior to Western blot completely abolished immune signals in both G2-phase HS68 (lane 3) and REF52 cells (lane 4). 
(Lane 6) Western blot of bacterial lysate containing human p55  cdc2s protein using anti-edc25 peptide antibody r  Arrowhead is the 
p55  '~c2~ band. (B) Sequences of the peptides C5XR1 and C5XR2 are shown in comparison with cdc25 protein sequences from various 
species, and with different tyrosine phosphatases in the region corresponding to the catalytic site. Conserved amino acids are indicated 
by an asterisk. Amino acids identical to C5XR1 sequence are underlined. Also given on the right is the total number of  amino acids identical 
to the one in the C5XR1 sequence. 
man cdc25 protein (Millar et al.,  1991).  Finally, we have 
controlled the absence of cross-reactivity of aC5XR1  to- 
wards other nonrelated tyrosine phosphatase. In the condi- 
tions used to detect by blot cdc25 proteins, we have observed 
no cross-reactivity with tyrosine phosphatase type 1B (data 
not shown). 
To assess the expression profile of  cdc25 protein during the 
cell cycle of nontransformed mammalian cells, we have used 
REF52 and HS68 cells synchronized  through serum depriva- 
tion for 30 h. Under these conditions for cell synchroniza- 
tion, we have shown elsewhere (Lamb et al.,  1990;  Girard 
et  al.,  1991) that  Gl-phase  covers  the  period 0-16  h  in 
REF52, S-phase the period 16-19 h (peaking at 18 h), and 
G2-phase the period 19-24 h  when cells enter mitosis. At 
different  times after serum addition, cells were lysed and the 
presence of cdc25 protein was examined through immuno- 
blotting using aC5XR1.  Fig. 2  shows a typical expression 
profile for cdc25 protein in HS68 (Fig. 2 A) and REF52 cells 
(Fig. 2 B). In HS68, the major 67-kD protein species is de- 
tected at all times after serum addition (Fig. 2 A), together 
with the less abundant 38-kD protein (data not shown), a re- 
sult also observed in REF52 cells together with the 38- and 
75-kD bands (Fig. 2 B). Quantification of the immunoblot 
by scanning revealed that no major change in the level of the 
cdc25 67-kD protein occurs during the cell cycle (Fig. 2 A). 
In contrast, the smaller band at 38 kD appears to undergo 
changes in levels with a detectable increase at a time corre- 
sponding to S-phase, and a second increase at 24 h, corre- 
sponding to mitosis in REF52 cells. Such changes, however, 
are not detected in the levels of the 38-kD protein present as 
a  minor band in HS68 cells (data not shown).  While the 
significance of these variations in REF52 cells is not clear, 
they might be relevant if  this 38-kD fragment still carries the 
catalytic activity of cdc25 protein, a point that requires fur- 
ther investigations. To confirm the good synchronization of 
the cells in this study, we blotted the same cell extracts with 
anticyclin A antibody, and showed that cyclin A is detected 
from 16-24  h  in REF52 cells, and 14-24 h  in HS68  (not 
shown).  Similarly, the levels of t>34  ~  show little or no 
changes  throughout the  cell  cycle in  these  synchronized 
REF52 and HS68 cell extracts (not shown). 
Cytolocalization  of  cdc25 Protein in Nontransformed 
Mammalian Cells 
Since we have observed no changes in edc25 protein levels 
during the cell cycle of nontransformed fibroblasts, we next 
examined cdc25  intracellular distribution by  indirect im- 
munofluorescence  using the same ctC5XR1 antibody. REF52 
and  HS68  ceils  growing onto glass  coverslips  and  syn- 
chronized exactly as described above were used. In REF52 
cells,  cdc25  is  essentially localized in the nucleus at all 
stages of interphase, with a low level of cytoplasmic staining 
similar in intensity to the background cytoplasmic staining 
obtained with the preimmune serum (data not shown). Fig. 
3 shows the staining obtained with anti-cdc25 peptide anti- 
body in G1- (A and B) and S-phase cells (C and D). Detailed 
analysis revealed cdc25 staining distributes evenly through- 
out the nuclear material. We observed no evidence that this 
staining was excluded from the nucleoli (in marked contrast 
with cyclin A protein). Furthermore, cdc25 staining also ap- 
Girard et al. Localization of cdc25 Protein  787 Figure 2.  cdc25 is constitu- 
tively  expressed throughout 
the  cell  cycle of  nontrans- 
formed  mammalian  fibroblasts. 
Cell cycle expression profile 
of cdc25 protein was  exam- 
ined through Western blotting 
of whole  cell  extracts from 
HS68  (,4) and  REF52 cells 
(B),  prepared  from  syn- 
chronized  populations  of 
cells.  Synchronization was 
achieved through 30 h of se- 
rum  deprivation, then  re- 
stimulation  through serum ad- 
dition. Cells were scraped in 
boiling SDS sample buffer at 
the indicated times (in hours) 
following serum stimulation. 
Proteins  were separated on 
12%  SDS-PAGE, transferred 
to nitrocellulose, and probed 
for the presence of cdc25 pro- 
teins with c~C5XR1. The sym- 
bols represent  the different  pro- 
tein species  detected in REF52 
and HS68 cells as described in 
Fig. 1. Molecular masses are 
given in kilodaltons. Quanti- 
fication of the immune signal 
obtained in HS68 cell extracts 
was done  using  Shimadzu  Scan- 
ner,  and  is  referred to  the 
Western blot in A, at the same 
indicated times. 
pears to concentrate at the periphery of the nucleus as if as- 
sociated with the nuclear envelope. More detailed analysis 
reve~ed that this particular staining represents a fine punc- 
tate pattern made up of numerous spots of fluorescence, par- 
ticularly discernable in G2-phase and early prophase before 
the nuclear envelope breakdown (Figs. 4, A and B and 5, A 
and B).  Similar staining is also observed in human HS68 
fibroblasts at all stages of interphase (shown in Fig. 4, E and 
F  are  G2-phase  HS68  ceils  stained  with  ~C5XR1).  To 
confirm this  nuclear  localization,  we  incubated  affinity- 
purified antiserum with peptide C5XR1 alone, or with a mix- 
ture  of  both  C5XR1  and  C5XR2  peptides,  before  im- 
munofluorescence experiments. As shown in Fig. 4 (C and 
D), preincubation completely eliminates nuclear staining, 
including that associated with the nuclear envelope, thus, 
strongly suggesting that both the staining within the nucleus 
and at the nuclear periphery represent the true locale of the 
cdc25 protein in REF52 ceils. This localization of cdc25 pro- 
tein was confirmed using the antibodies directed against the 
purified human cdc25 protein using REF52, HS68 and HeLa 
ceils (data not shown). If the conditions were changed to use 
either simultaneous extraction/fixation in -20"C methanol 
or formalin fixation  followed  or preceAed by extraction in 1% 
Triton X100, we observed no difference in the nuclear pat- 
tern of distribution of cdc25 staining (not shown). 
To examine the distribution of cdc25 protein during mito- 
sis, REF52 cells were fixed 24 h after serum stimulation and 
stained  by  indirect  immunofluorescence with  anti-cdc25 
peptide antibodies. Fig. 5 shows fluorescent  micrographs ob- 
tained with c~C5XR1 and Hoeehst DNA staining of the same 
cells at various stages of mitosis. During early prophase, as 
chromatin condensed,  cdc25  staining remains  essentially 
nuclear, retaining the more intense peripheral nuclear stain- 
ing (Fig, 5, A and B). We observed no evidence of an associ- 
ation with chromatin as it condenses, as judged by compar- 
ing cdc25 staining (A) and Hoechst DNA staining (B) of the 
same cell. As nuclear envelope completely dissolves, cdc25 
staining spreads throughout the cytoplasm, with a more in- 
tense staining in the region corresponding to the mitotic 
spindle (shown in Fig. 5 are a prometaphase [C and/9] and 
a metaphase cell [E and FI). As the duplicated chromosomes 
move apart during anaphase, cdc25  staining remains dis- 
tributed in the whole cell, with a more intense staining of the 
material associated with the peripheral chromatin (Fig. 5, G 
and H). Once anaphase is completed and the two daughter 
ceils begin to  reform a  nuclear envelope,  cdc25  staining 
again becomes dearly relocalized within the nucleus, as the 
level of cytoplasmic staining diminishes to a level similar to 
that observed in interphase cells (Fig. 5, I and J). These ob- 
servations have been reproduced using the polyclonal anti- 
The Journal  of Cell Biology,  Volume 118, 1992  788 Figure 3. Nuclear distribution of cdc25 protein during G1 and S-phase. To determine the intracellular distribution of cdc25 protein during 
the mammalian cell cycle, REF52 cells were synchronized  through 30 h of serum deprivation. Subsequently,  cells were restimulated  through 
serum addition and formalin fixed at different intervals after serum addition. Cells were stained by indirect immunofluorescence  with 
,C5XR1,  followed  by incubations with biotinylated anti-rabbit and streptavidin Texas red as described in Materials and Methods. Shown 
are fluorescent micrographs (A and C) and phase contrast (B and D) of Gl-phase (.4 and B) and S-phase REF52 cells (C and D), fixed 
and stained, respectively, 7 and 17 h after serum stimulation. Bar, 5/zm. 
bodies against human cdc25.  We have also found a similar 
profile of distribution with HS68  cell line using o~C5XR1 
(data not shown). To examine in more detail the kinetics of 
the changes in cdc25 protein distribution during prophase, 
we have performed double immunofluorescence  experiments 
in which HS68 cells were stained for cdc25 protein with 
o~C5XR1 together  with  staining  for  lamins  with  a  mAb 
against human lamins A and C. Results are presented in Fig. 
6. cdc25 staining is still essentially localized in the nucleus 
in early prophase (Fig. 6 A), as judged by the low level of 
chromatin condensation (Fig.  6  C) and lamin staining re- 
stricted to the nucleus (Fig.  6 B).  At the transition from 
prophase to prometaphase as some lamin staining begins to 
distribute throughout the cytoplasm with the nuclear enve- 
lope still clearly defined (Fig. 6 E), there is already a dra- 
matic decrease in the cdc25 nuclear staining (Fig. 6 D). In 
this late prophase cell, in which chromatin is highly con- 
densed (Fig. 6 F) and nuclear envelope not completely dis- 
solved, we observe a quantitative increase in the cytoplasmic 
cdc25 staining (Fig. 6 D).  These observations suggest that 
part of cdc25 proteins leaves the nucleus to be redistributed 
into the cytoplasm before the complete loss of the nuclear 
envelope. 
Since there appears to be a close liaison between the local- 
ization of cdc25  in the nuclear periphery and the nuclear 
envelope, cells were analyzed by confocal scanning laser mi- 
croscopy to identify differences in locale between cdc25 and 
the nuclear envelope. Cells were fixed and stained for the 
locale of  cdc25 as described in Materials and Methods. After 
determining the overall sectional thickness of the nucleus 
(locating the uppermost point  and lowest point  at  which 
cdc25 fluorescence could be observed, on average 2.2-2.5 
/zm),  sectional planes of 300 nra were taken every 0.5 ~m 
through the  nucleus (six  on average).  For each  sectional 
plane, a summation of 70 images was taken. Shown in Fig. 
7 are three sections through a single nucleus at, respectively, 
point 0 (the uppermost section which just cuts into the nu- 
cleus) (A), 1.5/zm (the center of the nucleus) (B), and point 
2.5/zm (the lowest section of  the nucleus) (C). Clearly, com- 
paring B to A and C, cdc25 can be localized both throughout 
the nucleus and to the nuclear envelope. Since this is a single 
section through the center of the nucleus, there can be no 
contribution of the fluorescence in either upper  or lower 
planes. From these data we can conclude that cdc25 protein 
effectively  localized both intranuclearly and at the periphery 
of the nucleus. In addition, section in Fig. 7 B shows that 
there is little cdc25 staining in the nucleus. 
Discussion 
Proteins homologous to the product of the S. pombe cdc25 
gene are protein phosphatases that can activate the p34~V 
Girard et al. Localization of cdc25 Protein  789 Figure 4. Nuclear distribution of cdc25 protein during G2-phase. Cellular distribution of edc25 protein was examined during G2-phase 
of the cell cycle. Serum synchronized  REF52 and HS68 cells were formalin fixed  during G2, respectively,  22 and 20 h after serum stimula- 
tion, and stained with c~C5XR1 as described in Fig. 3. (A and B) fluorescent micrographs and phase contrast of G2-phase REF52 cells 
stained with ctC5XR1. (C and D) G2-phase REF52 cells stained with o~C5XR1 preincubated with C5XR1 peptide. (E and F) Fluorescent 
micrographs and phase contrast of G2-phase HS68 ceils stained with c~C5XR1. Bar, 5 ~m. 
cyclin B kinase by dephosphorylation of the p34  ~  subunit. 
To characterize both the expression and cellular localization 
of cdc25 proteins during the cell cycle of nontransformed 
mammalian cells,  we  have developed  antibodies directed 
against a peptide sequence C5XR-I, a highly conserved mo- 
tif  within the catalytic  domain of  the cdc25 gene family  pres- 
ent from yeast to man. Between the three different isoforms 
of human cdc25 proteins recently identified (named cdc25- 
A, -B, -C; Sadhu et al., 1990; Galaktionov and Beach, 1991; 
Nagata et al.,  1991), this region is 100%  identical. In light 
of  this high level of  conservation we anticipated that antibod- 
ies directed against C5XR-1 would detect different forms of 
cdc25 in different mammalian species with similar sensitiv- 
ity. Two amino acids within this region (cysteine and argi- 
nine in position 1 and 7 of  C5XR-1, respectively) are not only 
conserved among members of the phosphotyrosine phospha- 
tase gene family, but have also been shown necessary for 
both the biological function and tyrosine phosphatase activ- 
ity of edc25  (Dunphy and Kumagai, 1991; Gautier et al., 
1991; Millar et al.,  1991),  and for the activity of tyrosine 
phosphatases in general (Streuli et al.,  1990;  Guan et al., 
1991). It is believed that these amino acids are directly in- 
volved in binding and releasing of phosphate groups by tyro- 
sine phosphatases (Streuli et al.,  1990;  Guan and Dixon, 
1991).  Consequently, we have based our choice of peptide 
on raising antisera that recognize this putative catalytic site 
The Journal  of Cell Biology, Volume 118, 1992  790 on  cdc25  proteins.  Indeed,  as  expected we observed that 
binding of anti-C5XR-1 antibodies to cdc25 results in strong 
inhibition of the phosphatase activity as assayed by dephos- 
phorylation of paranitrophenylphosphate (pNPP) or activa- 
tion of highly purified starfish p34cdc2/cyclin B prokinase 
by cdc25  (U.  Strausfeld,  F.  Girard,  and N.  Lamb, unpub- 
lished observations). 
Figure 5. Cellular distribution 
of edc25  protein  during  mi- 
tosis. To examine the intracel- 
lular locale  of cdc25  protein 
during the different phases of 
mitosis, REF52 cells were syn- 
chronized through 30 h of se- 
rum deprivation, then restim- 
ulated  upon  serum addition, 
and formalin fixed followed by 
acetone extraction 24 h there- 
after. Localization was deter- 
mined  by  indirect  immuno- 
fluorescence  with  ctC5XR1, 
followed by incubations  with 
biotinylated  antirabbit  and 
streptavidin  Texas red  as de- 
scribed in Materials and Meth- 
ods.  Before  mounting,  cells 
were stained with Hoechst dye 
to visualize the DNA. Shown 
are fluorescent  micrographs (A, 
C, E, G, I) and DNA staining 
(B, D, F, H, J) of an early pro- 
phase cell  (A and B),  a pro- 
metaphase  cell  (C and D), a 
metaphase cell (E and F), an 
early anaphase cell (G and H) 
and a telophase cell (land J), 
respectively. Bar, 5 #m. 
We have used these affinity-purified antibodies to deter- 
mine both the timing of expression and cellular distribution 
of the  cdc25  protein  in  two  nontransformed  mammalian 
fibroblast cell lines: rat REF52 and human HS68. Our results 
clearly show that the expression of the cdc25 67 kD protein 
is constant throughout the cell cycle. Furthermore, we have 
shown  that  in  these  cells,  cdc25  proteins  are  essentially 
Girard et al. Localization of cdc25 Protein  791 Figure 6. A proportion of edc25 proteins leave the nucleus before the complete nuclear envelope breakdown. Cellular distribution of cdc25 
protein during the early phases of mitosis was examined in serum-synchronized human HS68 cells, formalin fixed and acetone extracted 
22 h after serum stimulation. Cells were costained for both cdc25 using czC5XR1 and lamins using monoclonal antihuman lamins A and 
C as described in Materials and Methods, and stained for DNA with Hoechst dye before mounting. (,4 and D) cdc25 staining; (B and 
E) lamin staining; and (C and F) DNA staining of prophase HS68 cells. A-C show staining of an early prophase cell; D-F show a late 
prophase cell. Bar, 5/~m. 
localized into the nucleus throughout interphase.  This nu- 
clear locale remains until just before the complete nuclear 
envelope  breakdown. At this time (end of  prophase), staining 
for cdc25 becomes dispersed throughout the cytoplasm of 
these  mitotic cells.  During  telophase,  the cdc25  proteins 
relocate into the reforming nuclei.  Although it has previ- 
ously been shown that the levels of cdc25-C transcription 
change during the course of the HeLa cell cycle with an in- 
crease in cdc25 mRNA in G2-phase (Sadhu et al., 1991), an 
observation also made in fission yeast for both protein and 
mRNA levels (Moreno et al., 1990), our results are in agree- 
ment  with  the  recent  report  of  Russell  and  co-workers 
describing no major change in the level of cdc25 protein dur- 
ing the HeLa cell cycle (Millar  et al.,  1991).  These dis- 
crepancies might arise partly from the nature of cdc25 pro- 
tein  species  analyzed,  since  it is  now evident that  cdc25 
proteins form part of a gene family, with three different genes 
identified to date in human cells (Sadhu et al., 1990; Galak- 
tionov and Beach,  1991;  Nagata et al.,  1991). 
The nuclear distribution of cdc25 protein phosphatase is 
of importance with respect to the time and locale at which 
p34~2-cyclin B kinase is activated through dephosphoryla- 
tion  by  cdc25.  Cyclin  B  appears  to  be  localized  in  the 
cytoplasm of HeLa ceils, until just before nuclear envelope 
breakdown at prophase, when cyclin B proteins translocate 
to the nucleus, and is found associated to the mitotic spindle 
at metaphase (Pines and Hunter,  1991).  We have observed 
similar results in two different human cell lines (human em- 
bryonic fibroblasts and HS68) with the difference that we 
never saw any association of cyclin B with the condensed 
chromatin in the mitotic cells (E Girard, U. Strausfeld, A. 
Fernandez, and N. Lamb, unpublished observations). Our 
Figure 7. Analysis of the intranuclear localization of cdc25 protein by confocal scanning laser microscopy. G2-phase human fibroblasts 
HS68 were formalin fixed and acetone extracted as described in Materials and Methods. Ceils were sequentially incubated with anti-cdc25 
antibody (c~C5XR1), biotinylated antirabbit antibody, and Streptavidine-conjugated Texas red. Cells were examined by confocal scanning 
laser microscopy (Biorad MRC5 microscope). Shown are three sections over a single nucleus. (,4) Upper section; (B) section corresponding 
to the center of the nucleus; (C) lower section. Bar, 5/~m. 
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the course of the different phases of mitosis.  In particular, 
we have observed two features. First, cdc25 protein seems 
to  be  excluded  from  the  condensed  chromosomes  in  all 
stages of mitosis.  Second, it appears to transiently localize 
in the region of the mitotic spindle.  These two features of 
cdc25 staining at mitosis are similar to the localization ofcy- 
clin B we have observed during mitosis in the same cell lines 
(F. Girard, U. Strausfeld, A. Fernandez, and N. Lamb, un- 
published observations). With respect to the mitotic spindle 
distribution, this is also in agreement with the recent report 
in HeLa cells (Pines and Hunter, 1991). However, this report 
also  states  that cyclin  B  associates  to the  chromosomes, 
while we have clearly observed the opposite. A close corre- 
lation between the locale of cdc25 phosphatase and cyclin B 
in mitotic mammalian cells would be in good agreement with 
a recent report showing the physical association of cyclin B 
and cdc25 protein as a complex during mitosis in Xenopus 
oocytes (Jessus and Beach,  1992).  Therefore, p34~2-cyclin 
B complexes  must accumulate in an inactive form into the 
cytoplasm during G2-phase. In addition, traffic through the 
nuclear pores  is essential  for the  activation of p34  ~2  by 
cdc25-dependent  tyrosine dephosphorylation,  as shown by 
blocking  nuclear transport with wheat germ agglutinin,  a 
lectin that binds to giycoproteins of the nuclear pores, which 
inhibits  p34 ~2  dephosphorylation,  but  has  no  effect  on 
p34  ~2  tyrosine  phosphorylation  (Dunphy and  Kumagai, 
1991). We can postulate that p34c~:-cyclin B kinase activa- 
tion by cdc25 phosphatase involves one of two possibilities. 
Either it takes place in the cytoplasm, following the diffusion 
of cdc25  proteins from the nuclear fraction,  an event de- 
tected only after the nuclear envelope has begun to disassem- 
ble (Fig.  6); or it takes place in the nucleus where p34  cdc2- 
cyclin B complex translocates just  before any evidence  of 
free lamin staining appears in the cytoplasm. The fine timing 
of these changes in locale detected for cyclin B and cdc25 
would more favor the second possibility. However, it is cer- 
tainly harder to detect precisely the time at which cdc25 first 
appears in the cytoplasm,  since it involves an immediate vol- 
ume dilution,  than it is to assess  the reciprocal change in- 
volving staining for a protein in the nucleus. We have indeed 
observed a substantial decrease in the levels of nuclear cdc25 
staining as cells progress from early to late prophase, with 
both the affinity-purified otC5XR1 antibodies and polyclonal 
antiserum against human cdc25 protein (IgG fraction). How- 
ever, since the anti-cdc25 antibodies we have used in these 
studies are raised against the catalytic  site of cdc25 protein 
phosphatase, and presumably dephosphorylation of p34 '~2- 
cyclin B kinase involves the binding of the cdc25 phospha- 
tase to p34  ~z, thus masking the C5XRI  epitope,  we may 
explain the decrease in the cdc25  staining observed in late 
prophase as  resulting from this binding  event.  Therefore, 
more detailed examination would be necessary to determine 
where the cdc25-dependent activation of p34~2-cyclin  B ki- 
nase  occurs. 
Like cdc25 protein phosphatase and in contrast with cyclin 
B-dependent  kinase,  cyclin  A-dependent  kinase  is  also 
strictly localized into the nucleus (Girard et al., 1991; Pines 
and Hunter, 1991). It is still unclear if cdc25 phosphatase is 
also involved in the process of dephosphorylation/activation 
of p33cdk2-cyclin A kinase. This might be of importance in 
the understanding of the mechanisms that coordinate the dis- 
tinct roles of both cyclins A- and B-dependent kinases in the 
course of the cell cycle. 
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